Systems and methods for determining insulin therapy for a patient
First Claim
1. A non-transitory computer readable medium having stored therein instructions executable by a computing device to cause the computing device to perform functions comprising:
- receiving information associated with a glucose measurement value of a patient;
receiving information associated with anticipated nutrition intake for the patient;
receiving information indicating a short-acting insulin-on-board for the patient, wherein short-acting insulin-on-board is associated with an amount of short-acting insulin that remains in the patient due to a prior insulin administration;
based, at least in part, on the information associated with the glucose measurement value of the patient, the anticipated nutrition intake for the patient and the short-acting insulin-on-board, determining a short-acting subcutaneous insulin dosage recommendation;
or an intravenous insulin dosage recommendation;
receiving information indicating the confirmation of a nutrition intake for the patient;
receiving information indicating a long-acting insulin-on-board for the patient, wherein the long-acting insulin-on-board is associated with an amount of long-acting insulin that remains in the patient due to a prior insulin administration;
based, at least in part, on the information associated with the long-acting insulin-on-board for the patient, the glucose measurement value of the patient, and the confirmation of the nutrition intake for the patient, determining a required long-acting subcutaneous insulin dosage or a required intravenous insulin dosage for the patient;
adjusting the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation based on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage, such that;
the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is lowered if the difference between the lone-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is less than a predetermined value and/or the long-acting insulin-on-board is greater than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and
the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is increased if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is greater than the predetermined value and/or the long-acting insulin-on-board is less than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and
outputting an indication of the required long-acting subcutaneous insulin dosage, the short-acting subcutaneous recommendation or intravenous insulin dosage recommendation, or the required intravenous insulin dosage recommendation.
4 Assignments
0 Petitions
Accused Products
Abstract
In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.
62 Citations
25 Claims
-
1. A non-transitory computer readable medium having stored therein instructions executable by a computing device to cause the computing device to perform functions comprising:
- receiving information associated with a glucose measurement value of a patient;
receiving information associated with anticipated nutrition intake for the patient;
receiving information indicating a short-acting insulin-on-board for the patient, wherein short-acting insulin-on-board is associated with an amount of short-acting insulin that remains in the patient due to a prior insulin administration;
based, at least in part, on the information associated with the glucose measurement value of the patient, the anticipated nutrition intake for the patient and the short-acting insulin-on-board, determining a short-acting subcutaneous insulin dosage recommendation;
or an intravenous insulin dosage recommendation;receiving information indicating the confirmation of a nutrition intake for the patient; receiving information indicating a long-acting insulin-on-board for the patient, wherein the long-acting insulin-on-board is associated with an amount of long-acting insulin that remains in the patient due to a prior insulin administration; based, at least in part, on the information associated with the long-acting insulin-on-board for the patient, the glucose measurement value of the patient, and the confirmation of the nutrition intake for the patient, determining a required long-acting subcutaneous insulin dosage or a required intravenous insulin dosage for the patient; adjusting the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation based on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage, such that; the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is lowered if the difference between the lone-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is less than a predetermined value and/or the long-acting insulin-on-board is greater than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is increased if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is greater than the predetermined value and/or the long-acting insulin-on-board is less than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and outputting an indication of the required long-acting subcutaneous insulin dosage, the short-acting subcutaneous recommendation or intravenous insulin dosage recommendation, or the required intravenous insulin dosage recommendation. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- receiving information associated with a glucose measurement value of a patient;
-
20. A method for determining a patient therapy, the method comprising:
-
receiving information associated with a glucose measurement value of the patient, receiving information associated with anticipated nutrition intake for the patient; receiving information indicating a short-acting insulin-on-board for the patient, wherein short-acting insulin-on-board is associated with an amount of short-acting insulin that remains in the patient due to a prior insulin administration; based, at least in part, on the information associated with the glucose measurement value of the patient, the anticipated nutrition intake for the patient and the short-acting insulin-on-board, determining a short-acting subcutaneous insulin dosage recommendation, or an intravenous insulin dosage recommendation; receiving information indicating a confirmation of the nutrition intake for the patient; receiving information indicating a long-acting insulin-on-board for the patient, wherein long-acting insulin-on-board is associated with an amount of long-acting insulin that remains in the patient due to a prior insulin administration; based, at least in part, on the information associated with the long-acting insulin-on-board for the patient, the glucose measurement value of the patient, and the confirmation of the nutrition intake for the patient, determining a required long-acting subcutaneous insulin dosage or a required intravenous insulin dosage for the patient; adjusting the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage, such that; the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is lowered if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is less than a predetermined value and/or the long-acting insulin-on-board is greater than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is increased if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is greater than the predetermined value and/or the long-acting insulin-on-board is less than the required lone-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and outputting an indication of the required long-acting subcutaneous insulin dosage, the short-acting subcutaneous insulin dosage recommendation, or the intravenous insulin dosage recommendation. - View Dependent Claims (21, 22)
-
-
23. A system for determining a patient therapy, the system comprising:
- at least one processing unit;
memory storing instructions executable by the at least one processing unit for carrying out functions, the functions comprising;
receiving information associated with a glucose measurement value of the patient;
receiving information associated with anticipated nutrition intake for the patient, receiving information indicating a short-acting insulin-on-board for the patient, wherein short-acting insulin-on-board is associated with an amount of short-acting insulin that remains in the patient due to a prior insulin administration;
based, at least in part, on the information associated with the glucose measurement value of the patient, the anticipated nutrition intake for the patient and the short-acting insulin-on-board, determining a short-acting subcutaneous insulin dosage recommendation, or an intravenous insulin dosage recommendation to be administered to the patient;
receiving information indicating the confirmation of a nutrition intake for the patient, receiving information indicating a long-acting insulin-on-board for the patient, wherein long-acting insulin-on-board is associated with an amount of long-acting insulin that remains in the patient due to a prior insulin administration;
based, at least in part, on the information associated with the long-acting insulin-on-board for the patient, the glucose measurement value of the patient, and the confirmation of the nutrition intake for the patient, determining a required long-acting subcutaneous or a required intravenous insulin dosage for the patient;
adjusting the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage, such that the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is lowered if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is less than a predetermined value and/or the long-acting insulin-on-board is greater than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and
the short-acting subcutaneous insulin dosage recommendation or intravenous insulin dosage recommendation is increased if the difference between the long-acting insulin-on-board and the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage is greater than the predetermined value and/or the long-acting insulin-on-board is less than the required long-acting subcutaneous insulin dosage or the required intravenous insulin dosage; and
outputting the required long-acting subcutaneous insulin dosage, the short-acting subcutaneous recommendation or intravenous insulin dosage recommendation, the intravenous insulin dosage recommendation, or combinations thereof to be administered to the patient. - View Dependent Claims (24, 25)
- at least one processing unit;
Specification